Top Story

FANG vaccine stalls disease recurrence in ovarian cancer

April 1, 2015

Treatment with the immunotherapy vaccine FANG was associated with a high rate of T-cell activation and prolonged RFS in patients with stage III/IV ovarian cancer, according to phase 2 study results presented at the Society for Gynecologic Oncology Annual Meeting on Women’s Cancer.

“This is cutting-edge medicine for ovarian cancer,” Jonathan Oh, MD, a gynecologic oncologist at the Texas Oncology–Presbyterian Cancer Center in Dallas, said in a press release. “This immunotherapy may keep the cancer away longer.”

What is palliative care?

April 1, 2015
Palliative care — also known as supportive care or symptom management — is administered at the time of diagnosis of a serious illness, throughout the…
In the Journals

Morbidity increased among childhood cancer survivors

April 1, 2015
The projected increase in the number of survivors of childhood cancer has corresponded with an increase in the morbidity burden of this population, according to study…
Jeffrey Weber, MD In the Journals

Nivolumab demonstrates superiority to chemotherapy for advanced melanoma

March 31, 2015
Nivolumab was associated with a greater objective response rate and an improved toxicity profile compared with chemotherapy in patients with advanced melanoma who had…
Robert L. Coleman, MD Meeting News Coverage

Bevacizumab plus chemotherapy improves OS in recurrent ovarian cancer

March 31, 2015
The addition of bevacizumab to a standard chemotherapy regimen conferred a median 5-month survival improvement among women with ovarian cancer, according to results of a…
More News Headlines »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Meeting News Coverage Video
thumbnail for video 4126759064001

Solid organ transplant recipients at higher risk for skin cancer

March 22, 2015
SAN FRANCISCO – In this video, Sarah Tuttleton Arron, MD, PhD, FAAD, discusses her research on mortality from…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan